Plain-English translation of NCT06581861 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term research study designed to follow people who have a family history of ALS or who carry genes that put them at risk for developing the disease, even though they don't have symptoms yet. Researchers will collect blood samples, medical information, and recordings over 3 years to identify early biological changes that might one day help prevent or slow the disease. The study is funded by the National Institutes of Health and involves multiple medical centers across the country.
Most ALS treatments are given after someone already has symptoms, which is often too late to prevent serious damage. By studying people who are at genetic risk but haven't gotten sick yet, researchers hope to spot warning signs early and eventually develop ways to prevent the disease before it starts.
You likely qualify if…
You likely don't qualify if…
You would commit to 3 years of follow-up, which includes 4 in-person visits to a clinic each year and 6 remote check-ins by video or phone every 4 months. At each visit, you'll provide blood samples, answer questions about your health history, complete brief voice recordings, and fill out questionnaires. You may also optionally provide a spinal fluid sample or enroll in a genetic testing sub-study that involves 3 additional visits with genetic counseling.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States